Form 4 for ALHC Alignment Healthcare, Inc.
Accepted 2023-01-20 00:00:00 ET · period of report 2023-01-18 · accession 0001209191-23-004324 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-01-20 | 2023-01-18 | ALHC | KAO JOHN E | CEO, Dir | S - Sale | $13.01 | -1,100 | 2.72M | -0.0% | -$14.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-18 | S | D | 1,100 | $13.01 | 2,723,100 | I See Footnote | — | — | (F2) The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. (F3) Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. |